Supernus Pharmaceuticals, Inc. (SUPN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

32.79

+1.53

(+4.89%)

At close: 04:00PM EDT

32.79

0.00

(0.00%)

After hours:

07:06PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Momentum

View all chart patterns

Performance Outlook

Previous Close	31.26
Open	31.43
Bid	32.77 x 1100
Ask	32.78 x 900
Day's Range	31.06 - 32.79
52 Week Range	23.15 - 34.50
Volume	496,756
Avg. Volume	354,529

Market Cap	1.754B
Beta (5Y Monthly)	1.05
PE Ratio (TTM)	32.15
EPS (TTM)	1.02
Earnings Date	Nov 01, 2022 - Nov 07, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	36.75

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

-25% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SUPN

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Supernus Pharmaceuticals, Inc.
SUPN: Lowering target price to $29.00SUPERNUS PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $29.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
Rating
Fair Value
Economic Moat
2 months agoArgus Research